Levent Ündar

909 total citations
55 papers, 627 citations indexed

About

Levent Ündar is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Levent Ündar has authored 55 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 12 papers in Genetics and 10 papers in Oncology. Recurrent topics in Levent Ündar's work include Platelet Disorders and Treatments (9 papers), Blood disorders and treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Levent Ündar is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Blood disorders and treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Levent Ündar collaborates with scholars based in Türkiye, Cyprus and United States. Levent Ündar's co-authors include Ìhsan Karadoǧan, Erdal Kurtoğlu, Abdülkerim Kasım Baltacı, Serdar Akça, Cansel Türkay, Levent Korkmaz, Ozan Salim, Hasan Altunbaş, Gülsüm Özet and Emın Kaya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Levent Ündar

51 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levent Ündar Türkiye 14 286 132 124 84 80 55 627
Maryna Krawczuk‐Rybak Poland 12 124 0.4× 149 1.1× 123 1.0× 73 0.9× 57 0.7× 130 770
Andrzej Rydzewski Poland 15 187 0.7× 62 0.5× 43 0.3× 52 0.6× 44 0.6× 57 612
Peter Thye‐Rønn Denmark 12 92 0.3× 40 0.3× 110 0.9× 85 1.0× 118 1.5× 26 730
Carmen Duicu Romania 14 100 0.3× 37 0.3× 192 1.5× 41 0.5× 58 0.7× 55 528
Consuelo Corti Italy 13 283 1.0× 188 1.4× 62 0.5× 37 0.4× 22 0.3× 50 627
Türker Çetin Türkiye 13 171 0.6× 77 0.6× 69 0.6× 98 1.2× 38 0.5× 30 603
Matthias John Germany 13 89 0.3× 64 0.5× 133 1.1× 60 0.7× 391 4.9× 23 948
Rachel M. Pearce United Kingdom 14 430 1.5× 187 1.4× 93 0.8× 84 1.0× 47 0.6× 25 993
Peale Chuang United States 11 81 0.3× 42 0.3× 99 0.8× 49 0.6× 57 0.7× 15 733

Countries citing papers authored by Levent Ündar

Since Specialization
Citations

This map shows the geographic impact of Levent Ündar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Ündar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Ündar more than expected).

Fields of papers citing papers by Levent Ündar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levent Ündar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Ündar. The network helps show where Levent Ündar may publish in the future.

Co-authorship network of co-authors of Levent Ündar

This figure shows the co-authorship network connecting the top 25 collaborators of Levent Ündar. A scholar is included among the top collaborators of Levent Ündar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levent Ündar. Levent Ündar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salim, Ozan, et al.. (2022). The Prognostic Impact of Pretreatment Geriatric Nutritional Risk Index in Patients with Diffuse Large B-Cell Lymphoma. Nutrition and Cancer. 75(2). 591–598. 7 indexed citations
2.
Salim, Ozan, et al.. (2022). Outcomes of stem cell mobilization and engraftment in patients with multiple myeloma according to CD56 expression status. Transfusion and Apheresis Science. 61(3). 103351–103351.
3.
Ündar, Levent, et al.. (2022). Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature. Clinical Lymphoma Myeloma & Leukemia. 22(9). 702–707. 1 indexed citations
4.
Turan-Vural, Ece, et al.. (2021). Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome. Journal of Oncology Pharmacy Practice. 28(2). 500–503. 3 indexed citations
6.
Salim, Ozan, et al.. (2019). Investigation of seasonal frequency and pathogens in febrile neutropenia. memo - Magazine of European Medical Oncology. 12(2). 119–122. 1 indexed citations
7.
Çetin, Zafer, Ìhsan Karadoǧan, Alphan Küpesiz, et al.. (2012). Aberrations of Chromosomes 9 and 22 in Acute Lymphoblastic Leukemia Cases Detected by ES-Fluorescence In Situ Hybridization. Genetic Testing and Molecular Biomarkers. 16(5). 318–323. 1 indexed citations
8.
Timurağaoğlu, Ayşen, et al.. (2007). Improvement of Zoledronic Acid-Induced Jaw Osteonecrosis with Bortezomib. Acta Haematologica. 118(4). 203–204. 7 indexed citations
9.
Çolak, Dilek, Rabin Saba, Alphan Küpesiz, et al.. (2006). Cytomegalovirus Antigenemia and Outcomes of Patients Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation: Effects of Long-Term High-Dose Acyclovir Prophylaxis and Preemptive Ganciclovir Treatment. Japanese Journal of Infectious Diseases. 59(4). 216–221. 6 indexed citations
10.
Özdoğan, Mehmet, et al.. (2004). Sheehan's syndrome associated with pancytopenia due to marrow aplasia; full recovery with hormone replacement therapy. International Journal of Clinical Practice. 58(5). 533–535. 15 indexed citations
11.
Kurtoğlu, Erdal, et al.. (2003). Activity of Neutrophil NADPH Oxidase in Iron-Deficient Anemia. Biological Trace Element Research. 96(1-3). 109–116. 26 indexed citations
12.
Kurtoğlu, Erdal, et al.. (2003). Effect of Iron Supplementation on Oxidative Stress and Antioxidant Status in Iron-Deficiency Anemia. Biological Trace Element Research. 96(1-3). 117–124. 108 indexed citations
13.
Öğünç, Dilara, Meral Gültekin, Gözde Öngüt, et al.. (2002). Bacteremia caused by Brevibacterium species in a patient with chronic lymphocytic leukemia. PubMed. 32(2). 151–153. 7 indexed citations
15.
Ündar, Bülent, et al.. (1999). Flow Cytometric Analysis of Circadian Changes in Platelet Activation Using Anti-Gmp-140 Monoclonal Antibody. Chronobiology International. 16(3). 335–342. 14 indexed citations
16.
Altunbaş, Hasan, G. Yazicioglu, Mustafa Kemal Balcı, Ümit Karayalçın, & Levent Ündar. (1999). THE USE OF RECOMBINANT HUMAN G‐CSF IN THE TREATMENT OF PROPYLTHIOURACIL‐INDUCED AGRANULOCYTOSIS. International Journal of Clinical Practice. 53(5). 396–397. 1 indexed citations
17.
Ündar, Levent, et al.. (1999). Plasma Protein Z Levels Inversely Correlate with Plasma Interleukin-6 Levels in Patients with Acute Leukemia and Non-Hodgkin’s Lymphoma. Thrombosis Research. 94(2). 131–134. 27 indexed citations
18.
Altunbaş, Hasan, Ümit Karayalçın, & Levent Ündar. (1998). Glycemic Control and Coagulation Inhibitors in Diabetic Patients. Pathophysiology of Haemostasis and Thrombosis. 28(6). 307–312. 2 indexed citations
19.
Karadoǧan, Ìhsan & Levent Ündar. (1997). Automated Plateletpheresis Does Not Cause an Increase in Platelet Activation in Volunteer Donors. Therapeutic Apheresis. 1(2). 174–177. 19 indexed citations
20.
Ündar, Levent, Cansel Türkay, & Levent Korkmaz. (1989). Circadian Variation in Circulating Platelet Aggregates. Annals of Medicine. 21(6). 429–433. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026